WO2003062920A2 - Pochoirs elastomeriques pour cellules de microstructuration - Google Patents
Pochoirs elastomeriques pour cellules de microstructuration Download PDFInfo
- Publication number
- WO2003062920A2 WO2003062920A2 PCT/US2002/026003 US0226003W WO03062920A2 WO 2003062920 A2 WO2003062920 A2 WO 2003062920A2 US 0226003 W US0226003 W US 0226003W WO 03062920 A2 WO03062920 A2 WO 03062920A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stencil
- article
- mold
- precursor
- substrate
- Prior art date
Links
- 238000000034 method Methods 0.000 claims abstract description 86
- 239000002243 precursor Substances 0.000 claims abstract description 27
- 238000009832 plasma treatment Methods 0.000 claims abstract description 6
- 238000003825 pressing Methods 0.000 claims abstract description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 23
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 23
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 23
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims description 22
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 claims description 22
- 238000000206 photolithography Methods 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 7
- 229920005570 flexible polymer Polymers 0.000 claims description 5
- 229920002120 photoresistant polymer Polymers 0.000 claims description 5
- 239000004065 semiconductor Substances 0.000 claims description 5
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 239000000758 substrate Substances 0.000 abstract description 55
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- 238000010899 nucleation Methods 0.000 abstract description 10
- 238000004113 cell culture Methods 0.000 abstract description 4
- 230000001413 cellular effect Effects 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 78
- 239000000463 material Substances 0.000 description 20
- 238000001723 curing Methods 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 238000000465 moulding Methods 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 210000002950 fibroblast Anatomy 0.000 description 12
- 239000010410 layer Substances 0.000 description 11
- 229920000642 polymer Polymers 0.000 description 11
- 239000002609 medium Substances 0.000 description 9
- 239000011521 glass Substances 0.000 description 8
- 210000003494 hepatocyte Anatomy 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 238000000059 patterning Methods 0.000 description 6
- 229910052710 silicon Inorganic materials 0.000 description 6
- 239000010703 silicon Substances 0.000 description 6
- 239000004793 Polystyrene Substances 0.000 description 5
- 239000000512 collagen gel Substances 0.000 description 5
- 229920001971 elastomer Polymers 0.000 description 5
- 210000002510 keratinocyte Anatomy 0.000 description 5
- 229920002223 polystyrene Polymers 0.000 description 5
- 238000007789 sealing Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000003915 cell function Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000005060 rubber Substances 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000002313 adhesive film Substances 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- -1 polydimethylsiloxane Polymers 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 102000012422 Collagen Type I Human genes 0.000 description 2
- 108010022452 Collagen Type I Proteins 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- 229910052581 Si3N4 Inorganic materials 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000012292 cell migration Effects 0.000 description 2
- 229940096422 collagen type i Drugs 0.000 description 2
- 230000013228 contact guidance Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000012460 protein solution Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 239000005046 Chlorosilane Substances 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102400001368 Epidermal growth factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 235000010676 Ocimum basilicum Nutrition 0.000 description 1
- 240000007926 Ocimum gratissimum Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 229910005091 Si3N Inorganic materials 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000035605 chemotaxis Effects 0.000 description 1
- VNJCDDZVNHPVNM-UHFFFAOYSA-N chloro(ethyl)silane Chemical class CC[SiH2]Cl VNJCDDZVNHPVNM-UHFFFAOYSA-N 0.000 description 1
- YGZSVWMBUCGDCV-UHFFFAOYSA-N chloro(methyl)silane Chemical class C[SiH2]Cl YGZSVWMBUCGDCV-UHFFFAOYSA-N 0.000 description 1
- NBWIIOQJUKRLKW-UHFFFAOYSA-N chloro(phenyl)silane Chemical class Cl[SiH2]C1=CC=CC=C1 NBWIIOQJUKRLKW-UHFFFAOYSA-N 0.000 description 1
- KOPOQZFJUQMUML-UHFFFAOYSA-N chlorosilane Chemical class Cl[SiH3] KOPOQZFJUQMUML-UHFFFAOYSA-N 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 150000004292 cyclic ethers Chemical group 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical class C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 230000035926 haptotaxis Effects 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000011694 lewis rat Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000004377 microelectronic Methods 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 231100000065 noncytotoxic Toxicity 0.000 description 1
- 230000002020 noncytotoxic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 229920003986 novolac Polymers 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000004017 serum-free culture medium Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000007723 transport mechanism Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 238000009849 vacuum degassing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
- B01L3/5085—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/12—Specific details about manufacturing devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/069—Absorbents; Gels to retain a fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0819—Microarrays; Biochips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0829—Multi-well plates; Microtitration plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0887—Laminated structure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0893—Geometry, shape and general structure having a very large number of wells, microfabricated wells
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/12—Specific details about materials
- B01L2300/123—Flexible; Elastomeric
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/12—Well or multiwell plates
Definitions
- This invention generally relates to the micropatterning of surfaces and, in particular, to the micropatterning of cells on surfaces.
- Photolithography presents harsh conditions which can destroy the cells themselves. Clean-room facilities and other complex equipment are also required and such facilities and equipment are not readily accessible to most biologists.
- Photolithography is not amenable to controlling the molecular properties of a surface required for many sophisticated cell-biological experiments. In addition, photolithography modifies a surface only at the beginning of an experiment. Once cells are deposited, photolithography cannot be used to make further surface modifications.
- Electroluminescent Displays describes an elastomeric mask that can be used to fabricate certain device components.
- International Patent Application WO 01/70389, published September 27, 2001, entitled “Cell Patterning Technique” describes an elastomeric mask for cell patterning.
- This invention relates to the micropatterning of cells on surfaces.
- the subject matter of this application involves, in some cases, interrelated products, alternative solutions to a particular problem, and/or a plurality of different uses of a single system or article.
- the invention provides a method.
- One method includes the steps of providing a substantially enclosed mold constructed and arranged to produce an article having a plurality of channels passing through the article, where at least one of the plurality of channels having a cross-sectional dimension of less than 1 mm.
- the method also includes the steps of injecting a precursor of a flexible polymer into the mold, and curing the precursor to produce a flexible polymeric article.
- a method in another embodiment of the invention, which includes the steps of providing a mold able to produce an article having a plurality of channels passing through the article, where at least one of the plurality of channels having a cross-sectional dimension of less than 1 mm.
- the method also includes the steps of adding a precursor of a flexible polymer to the mold, and applying pressure to the precursor while curing the precursor to produce a flexible polymeric article.
- the method in yet another embodiment, includes the step of treating at least a portion of a surface of a flexible polymeric article using oxygen-plasma treatment.
- the article has a plurality of channels passing through the article, where at least one of the plurality of channels having a cross-sectional dimension of less than 1 mm.
- the invention provides a flexible polymeric article.
- One article comprises a first surface, an opposing second surface, and a plurality of channels connecting the first surface with the second surface. At least one of the plurality of channels has a cross-sectional dimension of less than 1 mm and a length of less than about 25 ⁇ m.
- the invention is directed to a system for molding an article.
- the system includes components, which, when assembled, define a molding space, which can be enclosed.
- the molding space can include openings from which excess mold and material can escape, or through which precursor material can be introduced.
- the enclosed molding space can include interior surfaces that are patterned, for example, with protrusions that extend partially or completely across the molding space, allowing molding of an article containing channels therethrough.
- the molding space can include at least one very narrow dimension and in a set of preferred embodiments, coincident with dimensions of molded articles described herein.
- the invention is directed to a method of making any of the embodiments described herein.
- the invention is directed to a method of using any of the embodiments described herein.
- Fig. l(A-F) schematically illustrate a stencil fabrication process using an injection technique
- Fig. 2 (A-F) schematically illustrate a stencil fabrication process using an applied pressure
- Fig. 3 illustrate photomicrographs of various cellular micropatterns
- Fig. 4 illustrates photomicrographs of stenciled cell cultures on various substrates.
- the present invention provides new fabrication methods and techniques for making and using articles such as stencils to micropattern cells.
- the fabrication techniques of the invention can be used to make stencils and other articles. Stencils or articles of the invention can be made according to these or other techniques. Some techniques may allow the fabrication of thinner stencils or other articles containing channels.
- the invention provides a system for selectively applying cells to predetermined regions on a substrate. A stencil is positioned adjacent to a substrate to cover some portions of the substrate, while allowing other portions of the substrate to remain uncovered.
- the stencil may have one or more channels passing through the stencil, and in certain cases, the channels may have a cross-sectional dimension of less than 1 mm.
- the stencil may be applied to a cell culture substrate in such a way as to form a microscopic cellular pattern on the substrate, and the stencil may form a seal or other watertight contact with the substrate in some cases.
- the stencil may be applied to a substrate before seeding.
- Cells for example, hepatocytes, fibroblasts, or keratinocytes, or any other adherent type of cell
- the stencil may be fabricated, for example, by injecting an elastomeric precursor into a mold, or by curing an elastomeric precursor while applying pressure.
- the surface of the stencil may also be oxidized, or it may be treated in such a way as to render the surface of the stencil more hydrophilic, for example, by treating the surface using oxygen-plasma treatment.
- the stencil may have any shape or structure able to produce a micropattern of cells on a substrate.
- the stencil may include, for example, a membrane containing holes, channels, or other similar structures, formed in or through the membrane.
- there is a channel within the stencil and preferably a plurality of channels within the stencil.
- the stencil can comprise first and second opposing surfaces where the channel passes through the stencil, connecting the first surface with the second surface.
- the channel may function to expose certain portions (a second portion) of the surface of the article, whereas a first portion of the article is shielded due to conformal contact of the article with the masking system.
- “conform” it is meant to define essentially continuous contact between the stencil and the portions of the substrate to be patterned. This is to be distinguished from, for example, a metal screen or a rigid polymer, each of which can contact a surface to be masked, but which may not be flexible enough to conformally contact the surface.
- the flexibility of the stencil may be provided by the use of, for example, an elastomeric stencil.
- the stencil can shield selected portions of the substrate by being brought into contact with those portions.
- the stencil (or similar articles) may be made of a polymeric material, and flexible polymeric materials are preferred in some embodiments of the invention.
- the stencil (or other articles made in accordance with the invention), comprises an elastomeric material.
- Epoxy polymers are characterized by the presence of a three-member cyclic ether group commonly referred to as an epoxy group, 1,2- epoxide, or oxirane.
- diglycidyl ethers of bisphenol A may be used, in addition to compounds based on aromatic amine, triazine, and cycloaliphatic backbones.
- Another example includes the well-known Novolac polymers.
- silicone elastomers suitable for use as component 12 include those formed from precursors including the chlorosilanes such as methylchlorosilanes, ethylchlorosilanes, phenylchlorosilanes, and the like.
- One useful silicone elastomer is polydimethylsiloxane.
- the stencil may be reusable in some cases.
- the stencil or other articles of the invention may contain additional features, such as structures that provide for mechanical stability. For example, any structure able to prevent the stencils from holding or sticking to themselves or to other surfaces may be used, such as ribs or braces.
- an annulus of material may be bonded to the stencil as shown in Fig.
- the stencil may be of a variety of shapes or dimensions.
- the stencil may be, for example, circular, rectangular, square, triangular, oval, or irregularly shaped.
- the stencil has a thickness of no more than about 1 mm; in other embodiments, no more than about 500 ⁇ m; in still other embodiments, no more than about 200 ⁇ m; in still other embodiments, no more than about 100 ⁇ m; and in other embodiments, no more than about 50 ⁇ m or 25 ⁇ m.
- thinner stencils may be created.
- the thickness of the stencil may be less than 20 ⁇ m, less than 15 ⁇ m, less than 10 ⁇ m, or less than 5 ⁇ m in some cases.
- the channels or holes of the stencil or other article can have a diameter of less than about 3 mm, less than about 1 mm, less than about 500 ⁇ m, less than about 250 ⁇ m, less than about 100 ⁇ m, less than about 50 ⁇ m, less than about 25 ⁇ m, less than about 10 ⁇ m, less than about 5 ⁇ m, less than about 2 mm, down to less than about 1.5 ⁇ m or 1 ⁇ m.
- the channels may connect one side or surface of the stencil with an opposed side or surface.
- the channels do not necessarily connect one side or surface of the stencil with the opposed side or surface; in some embodiments, at least a portion of the channels may not fully extend across the stencil.
- the channels may have any shape (e.g., having a rectangular, circular, or square cross-section), and any orientation through the stencil. In some cases, the channels may be formed directly or linearly through the article.
- the new molding techniques of the present invention may allow for thinner stencils to be created, where the minimum thickness of the stencil is limited only by its structural integrity of the stencil or other such article. The minimal structural integrity may be determined by those of ordinary skill in the art. It will be appreciated that the minimum thickness is, in part, controlled by the formulation of the prepolymer. For example, polymers having better cohesion, higher molecular weight, stronger interchain binding, higher degrees of crosslinking, or those polymers that can be made as thin films may result in polymeric stencils having greater structural integrity, such that the stencil may be thinner.
- the stencil may have any number of channels or holes.
- the stencil may have 1 channel, 9 channels, 25 channels, 100 channels, 300 channels, 500 channels, or 750 channels, depending on the application.
- large numbers of channels are possible, for example, thousands, tens of thousands, hundreds of thousands, or millions of channels.
- the number of channels and the shape of channels can be varied by any method known to one of ordinary skill in the art.
- the size or shape of the channel or hole may be selected to allow only the entry of one or a small number of cells within the channel. For example, if the diameter of the channel is roughly the diameter of a cell in suspension, or even 2-3 times as big as the diameter of the cell in suspension, it may fit only one or a few cells.
- the resolution of cells may depend on factors such as the height-to- width ratio of the holes or channels, or the thickness of the stencil. For example, in a thinner stencil or article, the walls may be easier to wet or to fill with cells, the channel- to-channel spacing may be smaller, or the creation of the master may be easier.
- an approximately 100-micron thick stencil containing roughly 40-micron diameter channels, each separated on the average by about 250 microns, may allow for the creation of single-cell micropatterns of certain cells such as keratinocytes (Fig. 4C).
- Fig. 4C keratinocytes
- the stencil comprises a polymer, preferably a flexible polymer.
- a preferred polymer is a polymeric elastomer that can form a seal against the surface of the article, preferably a conformal seal.
- "Seal" in this context means that when the stencil is sealingly engaged with a surface or substrate and a fluid is applied to the masked surface, the fluid is allowed to contact only those portions of the masked surface in register with channels of the stencil and the fluid does not pass under the stencil and contact shielded portions of the surface covered by solid portions of the stencil, so long as the fluid does not degrade the stencil or the surface to be patterned (in which case fluid could pass under the stencil due to degradation of the stencil and/or surface).
- the seal can prevent a protein solution from seeping under the stencil.
- "Sealing" in this context is to be distinguished from the operation of other rigid or flexible stencils that may be brought into conformal contact with a surface or other substrate, but that can not seal against the surface. It is a feature of the invention that stencils of the invention can form a seal against a substrate surface in the absence of any clamping apparatus or other apparatus used to apply a force against the stencil in a direction of the substrate surface. Where elastomeric surfaces are used, and the elastomeric surface and substrate surface to be masked are clean, sealing can occur essentially instantaneously upon contact without application of significant pressure, and sealing can be maintained without maintenance of any pressure. This sealing is reversible, that is, the stencil can be removed from the substrate surface by being peeled off, and can be reused on the same or a different substrate surface.
- the surface of the stencil may be oxidized, for example, using chemical oxidation or exposure of the surface to a plasma.
- exposure of the stencil to the plasma may result in exposed oxygen atoms that become hydroxyl groups able to carry a negative charge.
- Pre-oxidizing one or more surfaces of the stencil can render the stencil more hydrophilic, for example, allowing easier wetting of an aqueous solution through channels in the stencil, or allowing easier deposition of cells within the stencil.
- a stencil or other article of the invention may be treated in such a way as to make the surface more hydrophilic or hydrophobic.
- the stencil may be treated in such a way as to prevent the binding of cells to the surface, or to prevent gas bubbles from attaching to the surface of the stencil, for example, when the stencil is covered with water or media.
- Any suitable technique may be used for treating the surface.
- one suitable treatment to render the surface more hydrophilic is to treat the stencil with a plasma such as an oxygen plasma.
- the stencil or other article may be used with a wide range of substrates or surfaces, for example, biocompatible polymers, microelectronic or semiconductor chips, gels, tissue culture dishes, biological tissues, polymers such as polystyrene, a humid surface such as a collagen gel, or the like.
- the substrate may include metal oxides, such as silica, alumina, quartz, glass, and the like or derivatives thereof, or the substrate may include metals such as gold, silver and copper.
- the substrate may include a semiconductor material, such as silicon, GaAs, or Si 3 N 4 .
- the substrate or surface may be coated, for example, with a hydrophilic material. In one example, illustrated in Fig.
- a micropattern of hepatocytes is created on a collagen gel.
- contact between the stencil and the collagen gel may be tight enough to prevent cell suspension from falling into it, but loose enough for attached cells to send filopodia into it.
- the stencil was removed 24 hours after seating, and a second layer of collagen gel was added after the patterning step to produce a "sandwich configuration" of cells between two layers of collagen gels.
- Heterogeneous surfaces can also be patterned using the present invention, such as a microelectrode.
- Fig. 4A illustrates micropatterned cells a gold/chromium microelectrode pattern on glass.
- the substrate may be either a planar or non- planar surface, such as a glass cylinder, a Pasteur pipette.
- the surface is an irregular surface, for example, in an implantable structure.
- the micropattern of fibroblasts shown in Fig. 4B was created on an approximately 6 mm diameter glass cylinder (note that only few rows of the micropattern in Fig. 4B are in focus, due to the curvature of the surface).
- the flexibility of the stencil may facilitate release of the stencil from the substrate or surface.
- Any cell may be micropattemed with the present invention, for example hepatocytes, fibroblasts, or keratinocytes.
- micropatterns of cells may be created to simulate physiological conditions, or to enhance cell function.
- a micropattern of hepatocytes and fibroblasts maybe created using the methods of the invention to enhance hepatocyte function.
- Cells may also be micropattemed to study various phenomena, for example, cell growth, migration, differentiation, or wound healing.
- the methods of the present invention do not necessarily depend on such factors as cell type or medium formulation; thus, these variables may be changed between applications. For example, non-confluent islands or serum-free media may be desired for certain experiments, whereas multilayers of cells or serum-containing media may be required for others.
- the stencil is created in a "mold.”
- Articles other than stencils can be created in molds in accordance with the invention and it should be understood that where description of creation of a stencil in a mold as described herein, the invention encompasses formation of essentially any article in a mold.
- a prepolymeric substance is placed in the mold, then the substance is treated such that the prepolymeric substance forms an article of the invention.
- Any technique may be used for creating the mold.
- the mold, or a pattern or micropattern in the mold may be microfabricated or machined, for example, using various photolithographic or etching techniques.
- the mold is open to the atmosphere; however, in other embodiments, the mold may be enclosed or substantially enclosed, for example, to control environmental conditions within the mold.
- many stencils may be replicated many times from the same mold using techniques of the invention.
- a master wafer for use in the mold may be microfabricated containing photoresist posts having predetermined shapes or heights.
- the posts may become the "supporting columns" of a chamber, if an upper surface or a "roof is added to the master. If the posts do not extend to reach the upper surface, then a channel that does not cross to an opposed surface may result.
- the posts may be photolithographically defined on any suitable substrate, for example, a semiconductor wafer such as a Si 3 N -coated silicon wafer.
- a mold 10 may be prepared including, for example, a patterned surface 11 (which, as illustrated, includes a plurality of regularly-spaced protrusions 13 defining intervening indentations 15) created using, for example, photolithographic techniques.
- the mold can be provided with an upper wall or surface
- the upper surface 12 of the mold 10 may be formed of any material, for example, glass, plastic, rubber a translucent or transparent adhesive film. Upper surface 12 may be rigid or semi-rigid, depending on the application. In some embodiments, upper surface 12 may be a stack or include several layers of material. Suitable materials for the upper surface include, for example, plastic, glass, or rubber. In some embodiments, one or more openings 14 may be formed in upper surface 12, for example, to allow for a fluidic connection to a syringe 16 (Fig. IC) or another fluid transport mechanism, such as a valve, a pump, a tube, or a dispensing unit. Prepolymer 25 may then be injected into the mold.
- a syringe 16 Fig. IC
- Prepolymer 25 may then be injected into the mold.
- prepolymer 25 is added through one or more openings, for example, using a suitable pressure.
- prepolymer may be dispersed at the edges of the molding chamber, or at predetermined loading sites around the molding chamber, and suction applied to the opening to generate flow of polymer into or through the mold, directed towards the hole or holes (Fig. ID).
- the upper surface 12 may then be peeled off or otherwise removed, for example, before or after curing of the prepolymer (Fig. IE).
- the term "inject,” when used in conjunction with the mold refers to the introduction of a substance into the mold under pressure (i.e., under positive or negative pressure).
- the prepolymer may be dispensed within the mold before adding an upper surface, in embodiments including an enclosed mold.
- upper surface 12 may be added and pressed tightly against the bottom surface 19, which may squeeze out excess prepolymer 25 from the mold, for example, through predefined openings in the mold, or between the upper and lower surfaces.
- pressure may be applied until the master and the transparency come into intimate contact (Fig. 2D).
- the pressure may be applied from the top surface of the mold, the bottom surface of the mold, or through a combination of pressures applied to both surfaces.
- upper surface 12 may be separated from bottom surface 19 and the fabricated article 40 released (alternatively, the article may be removed from the mold before or during the curing process).
- Additional structures may be added to the stencil or article at any point, for example, before, during, or after curing.
- structures that prevent bending or distortion of the stencil may be added, as previously described.
- ribs, braces, or an anrtulus of material 42, as shown in Fig. IF, may be added to the stencil.
- the prepolymer may be cured or hardened by any suitable technique, depending on the nature of the prepolymer.
- the prepolymer comprises PDMS
- the prepolymer may be cured or hardened within the mold by heating the prepolymer to the curing temperature, for example, to a temperature of at least about 65 or 70 °C.
- other curing techniques may be required, for example, exposure of the article to a gas or a curing solution.
- the time chosen may be any length of time sufficient to allow the prepolymer to cure, for example, for 2 hours or 4 hours.
- the prepolymer may be overcured, for example, for 8 hours, 10 hours, 12 hours, or even longer in some cases.
- the stencil or article may be cleaned by any suitable solvent, for example, to remove unreacted prepolymer.
- the article may be cleaned using an organic solvent such as acetone, ethanol or isopropanol.
- the prepolymer may be cleaned using a plasma, for example, oxygen plasma treatment (which may also affect hydrophilicity of the stencil, as further described below), or a combination of techniques may be used.
- the various plasma treatments may also remove undesired contaminants from the stencil, in some cases.
- Certain problems may occur if bubbles of gas become trapped within the mold, especially if the prepolymer contains hydrophobic surfaces.
- a bubble of gas may become trapped within a stencil channel, for example, in a channel with a lateral dimension of less than 100 microns.
- One method of facilitating the release of gas bubbles from the stencil is to treat the surface of the stencil using oxygen plasma so as to render it hydrophilic.
- Other methods include placing the stencil in a low vacuum (e.g., at a pressure of approximately 15 mTorr or 20 mTorr), adding ethanol or another solvent to the solution that is able to lower surface tension, allowing the bubble sufficient time to dissolve in the liquid (e.g., about 24 hours, about 36 hours, or about 48 hours), or adding a surfactant to facilitate wetting (e.g., Tween, or a protein solution, such as a bovine serum albumin solution), hi some cases, a combination of these • methods may be used.
- the surface may be treated by ethanol or isopropanol, followed by vacuum degassing.
- the stencil may also be sterilized using any suitable technique known to those of ordinary skill in the art, for example, under ultraviolet light, or by immersion in a sterilizing solution such as ethanol in water.
- the stencil or other article of the invention may then be used to micropattern cells on a surface, as previously described.
- Various techniques may be used to create the micropattern.
- a stencil may be sealingly bonded onto a substrate and manually pulled off after seeding of cells in some embodiments, or the stencil may left in place in other embodiments (for example, if the stencil comprises a nontoxic or noncytotoxic material). It is to be understood that the order of steps for shielding using the stencil, application of external agents and media, application of cells, and removal of the stencil (if desired) can be varied to obtain a desired result.
- the cells may be seeded at 25,000-50,000 cells/cm 2 to obtain a confluent monolayer of cells within each "island" or other pattern.
- higher or lower cell densities may also be used, for example, a density of 100 cells/cm 2 , 10,000 cells/cm 2 , 100,000 cells/cm 2 , or even 500,000 cells/cm 2 or 1,000,000 cells/cm 2 .
- the cells may be seeded for any suitable length of time, for example, a fixed length of time (e.g., 1 hour, 2 hours, 3 hours, or 4 hours), or for a time that allows a certain percentage of cells to attach to the substrate (e.g., when 50% or 70% of the cells have become attached to the surface).
- cells may be seeded at low densities and be allowed to grow, for example, until confluent or a certain percentage confluence is reached (e.g., about 70% confluent), or until a predetermined monolayer micropattern is achieved. In other embodiments, for example, where a monolayer of patterned cells is desired, high seeding densities may be used.
- the removal of the stencil may not result in damage to the cells immediately adjacent to the cell walls if the stencil is removed before attachment occurs, or, for "contact guidance" cells, the cells attached to the stencil may refuse to may contact with the cells attached to the surface and vice versa.
- Contact guidance cells are cells that generally are able to respond to the topographic or local features of their environment.
- areas that remain free of cells after removing the stencil or other article may then be seeded with a second type of cell.
- a first area may be seeded with hepatocytes and a second area contiguous with the first area may be seeded with fibroblasts. i certain embodiments, this process may be repeated several times, thus allowing the micropatterning of third, fourth, fifth, sixth, or even more areas or types of cells.
- the resulting pattern of cells can be used for a variety of applications, including observing cell growth and spreading, cell migration, would healing chemotaxis, haptotaxis, morphogenesis, developing biology artificial organ studies and the patterning of multiple cell types.
- cell patterning can have long range applications in the study of regeneration, partial regeneration or healing of human organs and wounds, i.e. tissue engineering. Other applications involve biosensors.
- Example 1 This example details the microfabrication of a master used to produce a mold in one embodiment of the invention.
- a 50-300 micron layer of suitable photoresist was spun on a TET-grade silicon wafer coated with 150 run of Si 3 N 4 , dried at 95 °C on a hot plate, and exposed to collimated UV light through either a chrome mask or a high-resolution transparency mask pressed against the photoresist layer. The unexposed areas were dissolved in propylene glycol methyl ether acetate. The transparency masks were printed either at
- the features on the masks were designed to produce posts of various shapes and sizes on the master.
- the master was then used to produce elastomeric stencils, as discussed in other examples.
- a molding chamber fabricated using techniques similar to those described in Example 1 was filled with PDMS prepolymer.
- the molding chamber includes a bottom surface 10 having protrusions 13, and an upper surface 12. (also in Ex. 3) hi this example, the tissue culture substrates were fabricated to be circularly symmetric, but other shapes, of course, are possible.
- PDMS prepolymer was prepared as a mixture of two components, mixed at 10:1 by weight.
- the mixture was degassed to eliminate bubbles created during mixing by placing the PDMS prepolymer in a dedicated desiccator at low vacuum (e.g., about 30 Torr). Breaking the vacuum periodically was used to facilitate removal of bubbles from the surface of the mixture.
- the roof or upper surface of the mold 12 was made with a thin adhesive film applied to the master (Figs. IA and IB). For spaced columns, where sagging of the film onto the wafer could occur, pressure was applied to the upper surface, for example, using a 1-mm thick glass plate.
- the adhesive upper surface 12 was perforated with a small hole 14.
- a connector between the hole 14 and a syringe 16 mounted with a fitting 17 was made in this example with a flat piece of PDMS 22 in which a piece of silicon tubing 24 had been embedded.
- the flat PDMS piece was them positioned onto upper surface 12 so that the center of silicon tubing 24 coincided with hole 14, and the fitting (with the mounted syringe) was fitted into the protruding end of silicon tubing 24 (Fig. IC).
- PDMS prepolymer 25 was poured onto the perimeter of the chamber (for example, a chamber in the shape of a 2-inch diameter disk) and was introduced or drawn into the molding chamber 10 by applying suction pressure 26 from the hole (Fig. ID).
- the chamber was substantially filled with PDMS, it was placed in an oven at 65-70°C for about 12 hours (including 8 hours overcuring to minimize bleaching of monomers, which may affect cell function).
- the PDMS connector was removed, and the chamber was opened by removing the upper surface 12 (i.e., the adhesive film) with tweezers (Fig. IE).
- a thick (about 3 mm) PDMS annulus was slightly wetted with PDMS precursor and the bottom was placed on top of the open chamber.
- the assembly was cured again to cause the PDMS annulus to bond with the stencil. (Alternatively, the PDMS annulus could be bonded after separating the stencil from the master).
- the stencil was then peeled off with the help of tweezers under a dissection microscope to avoid tearing of small features (Fig. IF).
- this example illustrates a technique for using an injection process to fabricate an elastomeric stencil.
- This example illustrated in Fig. 2, describes a method of using a compression- molding process to realize a stencil.
- a master (Fig. 2A), fabricated using techniques similar to those described in Example 1, was covered with a prepolymer (Fig. 2B) and then a multilayer stack was used to form the mold chamber.
- INSERT AA A transparency film 12 was carefully lowered onto the prepolymer, allowing surface tension to pull the transparency into intimate and continuous or sealing contact with the prepolymer mixture, for example, to prevent any bubbles from forming at the interface (Fig. 2C).
- the flexibility of the film allowed for easier removal from PDMS molds after curing.
- the master/prepolymer/transparency stack was the clamped within a sandwich that included several layers, including flat aluminum plates (top and bottom, a rigid wafer, and a rubber sheath (top only), as shown in Fig. 2D).
- the top and bottom aluminum plates provided uniform force 32 onto the stack from both sides.
- the rubber sheath provided a mechanical buffer layer between the top aluminum plate and rigid wafer, insuring uniform pressure on the wafer and preventing cracking from non-uniformities in the aluminum plate.
- the polished rigid wafer produced a flat surface on top of the cured molds.
- the clamped PDMS prepolymer sandwich was then cured for about 3 hours at 100°C on a hot plate. After curing, all layers were removed except the transparency layer. The flexible transparency was then removed (Fig. 2E) and the think PDMS replica was peeled off from the master (Fig. 2F).
- This example therefore illustrates a technique to fabricate an elastomeric stencil using pressure.
- Example 4 This example illustrates the use of a stencil of the invention to pattern cells on a substrate.
- the stencil was washed with acetone and ethanol, dried and gently pressed against the tissue-culture surface of interest. In some cases, the stencil was cleaned and rendered hydrophilic in an oxygen plasma (200 W, 5 min) prior to applying it to the tissue-culture surface.
- the stencil/substrate assembly was then fully covered with deionized water either in air or in 100% CO 2 . To deliver water under CO 2 , the stencil-covered substrate was placed at the bottom of a beaker (about 25 cm high) that was continuously flushed with CO 2 . Since CO 2 is heavier than air, this method ensured that the gas contacting the stencil was CO 2 .
- the stencil After delivering the water, the stencil was brought out to air, which resulted in dissolution of the bubbles into the water.
- the whole procedure could be performed inside a tissue-culture hood in sterile conditions.
- ethanol was squirted directly onto the stencil/substrate under mnning water carefully avoiding static exposures to ethanol.
- the stencil/substrate assembly with fully wetted walls was sterilized by overnight UV light exposure in a tissue-culture hood. Prior to seeding, the stencil/substrate assembly was washed twice with medium to fully substitute the water in the wells with medium.
- rat hepatocytes were isolated and seeded and cultured in high-glucose Dulbecco-modified Eagle's medium, supplemented with 0.5 Units/L insulin, 14 ng/ml glucagon, 7.5 g/ml hydrocortisone, 20 ng/ml epidermal growth factor, and 10% fetal bovine semm.
- Mouse 3T3-J2 fibroblast were cultured in high-glucose (DMEM) supplemented with 10% calf semm and 2% penicillin/streptomycin mixture. Semm was heat-inactivated at 56°C for 30 min before being added to DMEM.
- fibroblasts were detached from the tissue-culture substrate with trypsin-EDTA, centrifuged at 100 rpm for 5 min and resuspended at 1 millionth cells/ml. Keratinocytes were isolated from human neonatal foreskins and cultured on a fibroblast feeder layer in keratinocyte basil medium. All cells were cultured in tissue-culture grade polystyrene petri dishes and incubated at 37°C in a humidified mixture of 9% air and 10% CO 2 . All percentages are by volume.
- HCl 0.1 mM pH 4 4
- 2 ml of the gelling solution composed of 9:1 collagen type I and concentrated DMEM was added and incubated for 1 hour at 37 °C to cause gelling.
- any excess medium was carefully aspirated from the dish.
- the hepatocyte cultures were covered with a second layer of 2 ml of freshly prepared gelling solution and incubated overnight. Finally, 2 ml over medium were added to each dish.
- the PDMS stencil was applied to the tissue-culture substrate, covered with deionized water, and bubbles were eliminated, water was substituted twice by the seeding medium prior to seeding.
- the stencil/substrate assembly was incubated at 37 °C for periods ranging from 2-48 hours to allow for cell attachment and spreading. After peeling off the stencil, the substrate was washed twice with seeding medium to remove unattached cells, thus resulting in a substrate with a micropattern of cells.
- this example illustrates the use of a stencil to produce a micropattern of cells on a substrate.
- Example 5 illustrated by the sequence of photomicrographs in Fig. 3, the depiction of a cellular micropattern by means of a 100-micron thick stencil containing
- the starting substrate was a tissue-culture-grade polystyrene petri dish and the cells were fibroblasts.
- a 100-micron thick stencil containing 140 micron-side squares separated by 100 microns was prepared using a technique similar to those described in
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002365249A AU2002365249A1 (en) | 2001-08-15 | 2002-08-15 | Elastomeric stencils for micropatterning cells |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31240501P | 2001-08-15 | 2001-08-15 | |
US60/312,405 | 2001-08-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003062920A2 true WO2003062920A2 (fr) | 2003-07-31 |
WO2003062920A3 WO2003062920A3 (fr) | 2003-10-09 |
Family
ID=27613173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/026003 WO2003062920A2 (fr) | 2001-08-15 | 2002-08-15 | Pochoirs elastomeriques pour cellules de microstructuration |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002365249A1 (fr) |
WO (1) | WO2003062920A2 (fr) |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6893850B2 (en) | 2000-03-17 | 2005-05-17 | President And Fellows Of Harvard College | Method for cell patterning |
US7070701B2 (en) | 2002-10-08 | 2006-07-04 | Seiko Epson Corporation | Manufacturing method of fine structure, optical element, integrated circuit, and electronic instrument |
EP2161043A1 (fr) * | 2008-09-05 | 2010-03-10 | Ecole Polytechnique Federale De Lausanne (Epfl) | Dispositif médical revêtu et procédé de revêtement d'un dispositif médical |
WO2014184687A1 (fr) * | 2013-05-17 | 2014-11-20 | Indian Institute Of Technology Kanpur | Matrices à base de microbes pour impression par microcontact et procédé de préparation et d'utilisation de ces dernières |
US20150004358A1 (en) * | 2012-02-09 | 2015-01-01 | Wonjae Jung | Free-standing polymer membrane having through-holes and method for manufacturing same |
WO2016149394A1 (fr) | 2015-03-17 | 2016-09-22 | President And Fellows Of Harvard College | Système automatisé de fabrication de membrane |
US10605805B2 (en) | 2015-09-14 | 2020-03-31 | Essenlix Corporation | Device and system for analyzing a sample, particularly blood, as well as methods of using the same |
US10628693B2 (en) | 2016-12-21 | 2020-04-21 | Essenlix Corporation | Devices and methods for authenticating a sample and use of the same |
US10807095B2 (en) | 2017-10-26 | 2020-10-20 | Essenlix Corporation | Making and tracking assay card |
US10830761B2 (en) | 2015-09-14 | 2020-11-10 | Essenlix Corporation | Device and system for collecting and analyzing vapor condensate, particularly exhaled breath condensate, as well as method of using the same |
US10948389B2 (en) | 2015-08-10 | 2021-03-16 | Essenlix Corporation | Bio/chemical assay devices and methods for simplified steps, small samples, accelerated speed, and ease-of-use |
US11156606B2 (en) | 2018-01-11 | 2021-10-26 | Essenlix Corporation | Homogeneous assay (II) |
US11237113B2 (en) | 2017-10-26 | 2022-02-01 | Essenlix Corporation | Rapid pH measurement |
US11243201B2 (en) | 2017-08-01 | 2022-02-08 | Essenlix Corporation | Sample collection, holding and assaying |
US11274996B2 (en) | 2017-02-07 | 2022-03-15 | Essenlix Corporation | Compressed open flow assay and use |
US11280706B2 (en) | 2017-08-01 | 2022-03-22 | Essenlix Corporation | Dilution calibration |
US11393561B2 (en) | 2017-10-13 | 2022-07-19 | Essenlix Corporation | Devices and methods for authenticating a medical test and use of the same |
US11510608B2 (en) | 2017-12-14 | 2022-11-29 | Essenlix Corporation | Devices, systems, and methods for monitoring hair |
US11523752B2 (en) | 2017-02-16 | 2022-12-13 | Essenlix Corporation | Assay for vapor condensates |
US11604148B2 (en) | 2017-02-09 | 2023-03-14 | Essenlix Corporation | Colorimetric assays |
US11609224B2 (en) | 2017-10-26 | 2023-03-21 | Essenlix Corporation | Devices and methods for white blood cell analyses |
US11648551B2 (en) | 2017-12-12 | 2023-05-16 | Essenlix Corporation | Sample manipulation and assay with rapid temperature change |
US11725227B2 (en) | 2017-08-01 | 2023-08-15 | Essenlix Corporation | Devices and methods for examining drug effects on microorganisms |
US11885952B2 (en) | 2018-07-30 | 2024-01-30 | Essenlix Corporation | Optics, device, and system for assaying and imaging |
US11883824B2 (en) | 2017-02-09 | 2024-01-30 | Essenlix Corporation | Assay using different spacing heights |
US11927560B2 (en) | 2017-02-08 | 2024-03-12 | Essenlix Corporation | Bio/chemical material extraction and assay |
US11940382B2 (en) | 2017-02-09 | 2024-03-26 | Essenlix Corporation | Assay with amplification |
US12007315B2 (en) | 2017-02-08 | 2024-06-11 | Essenlix Corporation | Sample collection and handling for delayed analysis |
US12066434B2 (en) | 2017-02-08 | 2024-08-20 | Essenlix Corporation | QMAX assays and applications |
US12181472B2 (en) | 2017-06-12 | 2024-12-31 | Essenlix Corporation | Homogeneous assay |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4022521A (en) * | 1974-02-19 | 1977-05-10 | Honeywell Inc. | Microscope slide |
US5324591A (en) * | 1987-03-06 | 1994-06-28 | Geo-Centers, Inc. | Deep ultraviolet photolithographically defined ultra-thin films for selective cell adhesion and outgrowth and method of manufacturing the same and devices containing the same |
US5512131A (en) * | 1993-10-04 | 1996-04-30 | President And Fellows Of Harvard College | Formation of microstamped patterns on surfaces and derivative articles |
US5593814A (en) * | 1989-06-03 | 1997-01-14 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Control of cell arrangement |
-
2002
- 2002-08-15 WO PCT/US2002/026003 patent/WO2003062920A2/fr not_active Application Discontinuation
- 2002-08-15 AU AU2002365249A patent/AU2002365249A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4022521A (en) * | 1974-02-19 | 1977-05-10 | Honeywell Inc. | Microscope slide |
US5324591A (en) * | 1987-03-06 | 1994-06-28 | Geo-Centers, Inc. | Deep ultraviolet photolithographically defined ultra-thin films for selective cell adhesion and outgrowth and method of manufacturing the same and devices containing the same |
US5593814A (en) * | 1989-06-03 | 1997-01-14 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Control of cell arrangement |
US5512131A (en) * | 1993-10-04 | 1996-04-30 | President And Fellows Of Harvard College | Formation of microstamped patterns on surfaces and derivative articles |
Cited By (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6893850B2 (en) | 2000-03-17 | 2005-05-17 | President And Fellows Of Harvard College | Method for cell patterning |
US7070701B2 (en) | 2002-10-08 | 2006-07-04 | Seiko Epson Corporation | Manufacturing method of fine structure, optical element, integrated circuit, and electronic instrument |
EP2161043A1 (fr) * | 2008-09-05 | 2010-03-10 | Ecole Polytechnique Federale De Lausanne (Epfl) | Dispositif médical revêtu et procédé de revêtement d'un dispositif médical |
WO2010026557A3 (fr) * | 2008-09-05 | 2010-08-19 | Ecole Polytechnique Federale De Lausanne (Epfl) | Dispositif médical revêtu et procédé de revêtement d’un dispositif médical destiné à réduire la fibrose et la formation de capsules |
JP2012501716A (ja) * | 2008-09-05 | 2012-01-26 | エコール ポリテクニック フェデラル ド ローザンヌ(ウーペーエフエル) | コーティングした医療用器具、ならびに線維症および被膜形成を低減するための医療用器具のコーティング方法 |
US20150004358A1 (en) * | 2012-02-09 | 2015-01-01 | Wonjae Jung | Free-standing polymer membrane having through-holes and method for manufacturing same |
WO2014184687A1 (fr) * | 2013-05-17 | 2014-11-20 | Indian Institute Of Technology Kanpur | Matrices à base de microbes pour impression par microcontact et procédé de préparation et d'utilisation de ces dernières |
EP3271127A4 (fr) * | 2015-03-17 | 2018-11-21 | President and Fellows of Harvard College | Système automatisé de fabrication de membrane |
WO2016149394A1 (fr) | 2015-03-17 | 2016-09-22 | President And Fellows Of Harvard College | Système automatisé de fabrication de membrane |
AU2016233335B2 (en) * | 2015-03-17 | 2021-03-25 | President And Fellows Of Harvard College | Automated membrane fabrication system |
US11654399B2 (en) | 2015-03-17 | 2023-05-23 | President And Fellows Of Harvard College | Method for micromolding a polymeric membrane having a pore array |
US11385143B2 (en) | 2015-08-10 | 2022-07-12 | Essenlix Corporation | Bio/chemical assay devices and methods for simplified steps, small samples, accelerated speed, and ease-of-use |
US10948389B2 (en) | 2015-08-10 | 2021-03-16 | Essenlix Corporation | Bio/chemical assay devices and methods for simplified steps, small samples, accelerated speed, and ease-of-use |
US10605805B2 (en) | 2015-09-14 | 2020-03-31 | Essenlix Corporation | Device and system for analyzing a sample, particularly blood, as well as methods of using the same |
US12276660B2 (en) | 2015-09-14 | 2025-04-15 | Essenlix Corporation | Device and system for analyzing a sample, particularly blood, as well as methods of using the same |
US10830761B2 (en) | 2015-09-14 | 2020-11-10 | Essenlix Corporation | Device and system for collecting and analyzing vapor condensate, particularly exhaled breath condensate, as well as method of using the same |
US11543408B2 (en) | 2015-09-14 | 2023-01-03 | Essenlix Corporation | Device and system for analyzing a sample, particularly blood, as well as methods of using the same |
US11415570B2 (en) | 2015-09-14 | 2022-08-16 | Essenlix Corporation | Rapid vapor condensate collection and analysis |
US10628693B2 (en) | 2016-12-21 | 2020-04-21 | Essenlix Corporation | Devices and methods for authenticating a sample and use of the same |
US11274996B2 (en) | 2017-02-07 | 2022-03-15 | Essenlix Corporation | Compressed open flow assay and use |
US12066434B2 (en) | 2017-02-08 | 2024-08-20 | Essenlix Corporation | QMAX assays and applications |
US12007315B2 (en) | 2017-02-08 | 2024-06-11 | Essenlix Corporation | Sample collection and handling for delayed analysis |
US11927560B2 (en) | 2017-02-08 | 2024-03-12 | Essenlix Corporation | Bio/chemical material extraction and assay |
US11604148B2 (en) | 2017-02-09 | 2023-03-14 | Essenlix Corporation | Colorimetric assays |
US11940382B2 (en) | 2017-02-09 | 2024-03-26 | Essenlix Corporation | Assay with amplification |
US11883824B2 (en) | 2017-02-09 | 2024-01-30 | Essenlix Corporation | Assay using different spacing heights |
US11523752B2 (en) | 2017-02-16 | 2022-12-13 | Essenlix Corporation | Assay for vapor condensates |
US12181472B2 (en) | 2017-06-12 | 2024-12-31 | Essenlix Corporation | Homogeneous assay |
US11725227B2 (en) | 2017-08-01 | 2023-08-15 | Essenlix Corporation | Devices and methods for examining drug effects on microorganisms |
US11796538B2 (en) | 2017-08-01 | 2023-10-24 | Essenlix Corporation | Sample collection, holding and assaying |
US11280706B2 (en) | 2017-08-01 | 2022-03-22 | Essenlix Corporation | Dilution calibration |
US11243201B2 (en) | 2017-08-01 | 2022-02-08 | Essenlix Corporation | Sample collection, holding and assaying |
US11393561B2 (en) | 2017-10-13 | 2022-07-19 | Essenlix Corporation | Devices and methods for authenticating a medical test and use of the same |
US10807095B2 (en) | 2017-10-26 | 2020-10-20 | Essenlix Corporation | Making and tracking assay card |
US11237113B2 (en) | 2017-10-26 | 2022-02-01 | Essenlix Corporation | Rapid pH measurement |
US11609224B2 (en) | 2017-10-26 | 2023-03-21 | Essenlix Corporation | Devices and methods for white blood cell analyses |
US11648551B2 (en) | 2017-12-12 | 2023-05-16 | Essenlix Corporation | Sample manipulation and assay with rapid temperature change |
US12226769B2 (en) | 2017-12-12 | 2025-02-18 | Essenlix Corporation | Sample manipulation and assay with rapid temperature change |
US11510608B2 (en) | 2017-12-14 | 2022-11-29 | Essenlix Corporation | Devices, systems, and methods for monitoring hair |
US11696723B2 (en) | 2017-12-14 | 2023-07-11 | Essenlix Corporation | Devices, systems, and methods for monitoring hair |
US11156606B2 (en) | 2018-01-11 | 2021-10-26 | Essenlix Corporation | Homogeneous assay (II) |
US11885952B2 (en) | 2018-07-30 | 2024-01-30 | Essenlix Corporation | Optics, device, and system for assaying and imaging |
Also Published As
Publication number | Publication date |
---|---|
WO2003062920A3 (fr) | 2003-10-09 |
AU2002365249A1 (en) | 2003-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003062920A2 (fr) | Pochoirs elastomeriques pour cellules de microstructuration | |
Folch et al. | Microfabricated elastomeric stencils for micropatterning cell cultures | |
Branch et al. | Microstamp patterns of biomolecules for high-resolution neuronal networks | |
AU2001243656B2 (en) | Cell patterning technique | |
Kim et al. | Fabrication of nanostructures of polyethylene glycol for applications to protein adsorptionand cell adhesion | |
Tourovskaia et al. | Micropatterns of chemisorbed cell adhesion-repellent films using oxygen plasma etching and elastomeric masks | |
US6455311B1 (en) | Fabrication of vascularized tissue | |
JP4507845B2 (ja) | 細胞培養容器、及び培養細胞 | |
AU2001243656A1 (en) | Cell patterning technique | |
Folch et al. | Stacks of microfabricated structures as scaffolds for cell culture and tissue engineering | |
WO2003061585A2 (fr) | Systemes de criblage de candidats medicaments bases sur des hydrogels microstructures et des systemes microfluidiques | |
WO2009086535A2 (fr) | Systèmes et procédés de formation de matériaux de matrice extracellulaire comportant un motif | |
US8906282B2 (en) | Micro-structured and nano-structured surfaces on biodegradable polymers | |
WO2017087693A2 (fr) | Réseau de micropuits à base d'hydrogel personnalisable | |
US7655457B2 (en) | Cell culture vessel and cultured cell | |
CN102382765B (zh) | 图案化共培养多种细胞的装置、其制备方法及用途 | |
EP3922431A1 (fr) | Procédé de fabrication de microdispositifs pour des applications de laboratoire sur puce | |
US20090022896A1 (en) | Method for Producing a Structured Elastomer and Elastomer | |
Shrirao et al. | A versatile method of patterning proteins and cells | |
Snyder et al. | Fabrication of multiple microscale features on polymer surfaces for applications in tissue engineering | |
US20070231850A1 (en) | Patterned Cell Network Substrate Interface and Methods and Uses Thereof | |
KR101986016B1 (ko) | 단일 세포 트래핑 장치 및 제작 방법 | |
Snyder et al. | Microscale three-dimensional polymeric platforms for in vitro cell culture systems | |
KR102159231B1 (ko) | 세포 배양용 용기 및 이의 제조방법 | |
Lee et al. | Fabrication of micro patterned fibronectin for studying adhesion and alignment behavior of human dermal fibroblasts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase in: |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |